The effect of oral Aprepitant and Ondansetron injection on postoperative nausea and vomiting
Not Applicable
- Conditions
- nausea and vomitting.Nausea and vomiting
- Registration Number
- IRCT2016120831302N1
- Lead Sponsor
- Vice President of Research, Kurdistan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
women between 18 to 50 years old with ASA class 1 and 2 with at least 2 criteria of APFEL (female; nonsmoker; motion sickness or PONV history; using opioids 100mcg fentanyl or equivalent )
Exclusion criteria: women under 18 or greater than 50 years old; AA class 3 or more; cholecystectomy in other anesthesia; systemic disease like diabetes; asthma; cardiovascular; reflux, severe obesity; pregnancy; breast feeding; hepatic and renal disease; neuromuscular disease; psychotic disease; addiction; acute cholecystitis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea and vomitting. Timepoint: 6 and 24 hours after operation. Method of measurement: VAS criteria.
- Secondary Outcome Measures
Name Time Method Hospitalization period. Timepoint: at discharge time. Method of measurement: hospitalization days.